Preparation and evaluation of new eye-drops containing a combination of ciprofloxacin and dexamethasone

Indian Drugs

Volumn 37, Issue 4, 2000, Pages 190-195

  Doshi, H A ^a   Bhalla, H L ^b  

^a B V PATEL PHARMACEUTICAL EDUCATION AND RESEARCH DEVELOPMENT PERD CENTRE   (India)

^b SciTech Centre   (India)

Author keywords

Ciprofloxacin; Development; Dexamethasone; Efficacy; Eyedrops; Safety; Stability

Indexed keywords

CIPROFLOXACIN; CIPROFLOXACIN PLUS DEXAMETHASONE; DEXAMETHASONE; EYE DROPS; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPERGILLUS NIGER; CANDIDA ALBICANS; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG SCREENING; ESCHERICHIA COLI; EYE; EYE INFLAMMATION; FEMALE; KERATITIS; MALE; NONHUMAN; PSEUDOMONAS AERUGINOSA; RABBIT; STAPHYLOCOCCUS AUREUS;

EID: 0034099128     PISSN: 0019462X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Limberg M.B., Am J. Ophthalmol. (1991), 112, 2S.
2. Weiss S., New Engl. J. Med. (1989), 320, 365.
3. Neu H.C., Am. J. Ophthalmol., (1991) 112, 15S.
4. Frangie J.P. and Leibowitz H., Int. Ophthalmol. Clin. (1993), 33(4), Fall, 9.
5. Santoni G., Tonsini A., Gratteri P., Mura P., Furlanetto S and Pinzauti S., Int. J. Pharm., (1993), 93, 239.
6. Gilman M.R., in Hayes A.W. eds. "Skin and eye testing in animals," Principles and methods of toxicology, Raven Press, NY 1986,pp. 209-212.
7. Loftsson T., Fridriksdottir H, Thorisdottir S and Stefansson E., Int. J. Pharm. (1994), 104, 181.
8. Novack G.D., Am. J. Ophthalmol. (1992), 114(3), 357.
9. Callegan M.C., Hobden J.A., Jill J.M. Insler M.S. and O'callaghan R.J., Invest Ophthalmol. Vis. Sci. (1992) 33 (11), 3017.
10. Sugar A. Cohen M.A., Bien P.A., Griffin T.J. Heifetz C.L. Mehta S., Arch. Ophthalmol. (1986), 104, 1230.
11. Tommila P., Summanen P. and Tervo T., Acta Ophthalmol. (1987), 65(suppl), 182(89).
12. Nikolic L., Friend J., Taylor S and Thoft R.A., Invest. Ophthalmol. Vis. Sci., (1986), 27(4), 449.